Ablation of PRMT6 Reveals a Role As a Negative Transcriptional Regulator of the P53 Tumor Suppressor
Overview
Authors
Affiliations
Arginine methylation of histones is a well-known regulator of gene expression. Protein arginine methyltransferase 6 (PRMT6) has been shown to function as a transcriptional repressor by methylating the histone H3 arginine 2 [H3R2(me2a)] repressive mark; however, few targets are known. To define the physiological role of PRMT6 and to identify its targets, we generated PRMT6(-/-) mouse embryo fibroblasts (MEFs). We observed that early passage PRMT6(-/-) MEFs had growth defects and exhibited the hallmarks of cellular senescence. PRMT6(-/-) MEFs displayed high transcriptional levels of p53 and its targets, p21 and PML. Generation of PRMT6(-/-); p53(-/-) MEFs prevented the premature senescence, suggesting that the induction of senescence is p53-dependent. Using chromatin immunoprecipitation assays, we observed an enrichment of PRMT6 and H3R2(me2a) within the upstream region of Trp53. The PRMT6 association and the H3R2(me2a) mark were lost in PRMT6(-/-) MEFs and an increase in the H3K4(me3) activator mark was observed. Our findings define a new regulator of p53 transcriptional regulation and define a role for PRMT6 and arginine methylation in cellular senescence.
Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells.
Eudenbach M, Busam J, Bouchard C, Rossbach O, Zarnack K, Bauer U Life Sci Alliance. 2025; 8(4).
PMID: 39900436 PMC: 11791029. DOI: 10.26508/lsa.202402946.
Protein arginine methyltransferase 6 is a novel substrate of protein arginine methyltransferase 1.
Cao M, Feng Y, Zheng Y World J Biol Chem. 2023; 14(5):84-98.
PMID: 37901302 PMC: 10600687. DOI: 10.4331/wjbc.v14.i5.84.
Critical Roles of Protein Arginine Methylation in the Central Nervous System.
Chang K, Gao D, Yan J, Lin L, Cui T, Lu S Mol Neurobiol. 2023; 60(10):6060-6091.
PMID: 37415067 DOI: 10.1007/s12035-023-03465-x.
Wu K, Niu C, Liu H, Fu L Int J Oncol. 2023; 62(5).
PMID: 37026519 PMC: 10147102. DOI: 10.3892/ijo.2023.5510.
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Shi Y, Niu Y, Yuan Y, Li K, Zhong C, Qiu Z Nat Commun. 2023; 14(1):1932.
PMID: 37024475 PMC: 10079833. DOI: 10.1038/s41467-023-37542-5.